(Q47992122)
Statements
1 reference
Rationale and design of MARQUEE: a phase III, randomized, double-blind study of tivantinib plus erlotinib versus placebo plus erlotinib in previously treated patients with locally advanced or metastatic, nonsquamous, non-small-cell lung cancer (English)
1 reference
Lecia V Sequist
1 reference
Giorgio V Scagliotti
1 reference
Silvia Novello
1 reference
Joan H Schiller
1 reference
Vera Hirsh
1 reference
Joachim von Pawel
1 reference
Brian Schwartz
1 reference
Reinhard Von Roemeling
1 reference
Alan B Sandler
1 reference
21 March 2012
1 reference
13
1 reference
5
1 reference
391-395
1 reference